Promising asthma trial prompts Regeneron, Sanofi to push dupilumab into PhIII – FierceBiotech


Reuters

Promising asthma trial prompts Regeneron, Sanofi to push dupilumab into PhIII
FierceBiotech
Regeneron and its close partner Sanofi have cleared the final mid-stage hurdle for dupilumab in asthma patients, with several doses hitting the trial endpoint both for a subset of patients as well as the broad population. And the ambitious development
Sanofi's dual-action biotech asthma drug performs well in testReuters
Positive results for Sanofi/Regeneron's dupilumab in asthmaThe Pharma Letter

all 29 news articles »

View full post on asthma – Google News

Asmacure Posts Promising Phase 1/2a Asthma Drug Results – Drug Discovery & Development


Drug Discovery & Development

Asmacure Posts Promising Phase 1/2a Asthma Drug Results
Drug Discovery & Development
"The pharmacokinetics data from this study provided important information on the potential dose range for ASM-024 in the treatment of the moderate asthma patient when delivered as a dry powder for inhalation." ASM-024 is under development in a dry …

View full post on asthma – Google News

Initial Trials Show Promising Drug Treatment for Allergic Asthma – Headlines & Global News


Headlines & Global News

Initial Trials Show Promising Drug Treatment for Allergic Asthma
Headlines & Global News
"I've never seen anything quite like this," said Paul O'Byrne, the study's lead investigator and chairman of the executive committee of the nonprofit Global Initiative for Asthma. "It's too early to say if it's going be effective in treatment. But if
Amgen, Inc. (NASDAQ:AMGN) Zeroing In On Allergic Asthma Treatment With Big WallStreetPR

all 2 news articles »

View full post on asthma – Google News

Novel Biologic Promising for Allergic Asthma – MedPage Today


CTV News

Novel Biologic Promising for Allergic Asthma
MedPage Today
SAN DIEGO — A novel first-in-class biologic agent targeting allergic inflammation appeared promising for allergen-induced asthma in a phase IIb trial. AMG 157, an anti-thymic stromal lymphopoietin (TSLP) humanized monoclonal antibody, reduced most …
Researchers discover new potential antibody treatment for asthmaMedical Xpress
Canadian study finds potential antibody treatment for mild asthmaCTV News
Hamilton researchers discover potential asthma treatmentHamilton Spectator

all 11 news articles »

View full post on asthma – Google News

Steroid-sparing therapy is promising for allergic asthma – Skin and Allergy News Digital Network

Steroid-sparing therapy is promising for allergic asthma
Skin and Allergy News Digital Network
KEYSTONE, COLO. – A novel toll-like receptor-9 agonist showed impressive clinical efficacy in persistent allergic asthma in a double-blind, placebo-controlled clinical trial. "This is really interesting," Dr. Harold S. Nelson commented in highlighting

View full post on asthma – Google News

Target Promising in Asthma and Cancer – Drug Discovery & Development


Drug Discovery & Development

Target Promising in Asthma and Cancer
Drug Discovery & Development
Mice without the enzyme SKG1 were resistant to dust mite-induced asthma. In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target …
Novel Molecular Target for Asthma and Cancer IdentifiedGenetic Engineering News
`Immune system` regulating enzyme can help treat asthma and cancerDaily News & Analysis

all 13 news articles »

View full post on asthma – Google News

Enzyme Revealed As Promising Target To Treat Asthma And Cancer – RedOrbit


Counsel & Heal

Enzyme Revealed As Promising Target To Treat Asthma And Cancer
RedOrbit
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.
Novel Molecular Target for Asthma and Cancer IdentifiedGenetic Engineering News
`Immune system` regulating enzyme can help treat asthma and cancerDaily News & Analysis
Researchers Discover Enzyme That Could Be Promising Target To Treat Asthma Counsel & Heal

all 12 news articles »

View full post on asthma – Google News

Enzyme Revealed as Promising Target to Treat Asthma and Cancer – Newswise (press release)


ANINEWS

Enzyme Revealed as Promising Target to Treat Asthma and Cancer
Newswise (press release)
Newswise — In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain
`Immune system` regulating enzyme can help treat asthma and cancerDaily News & Analysis

all 6 news articles »

View full post on asthma – Google News